July 21, 2025

Stanford Physician-Scientist Takes CDER Helm

Stanford's George Tidmarsh appointed FDA's new CDER director, bringing 30+ years biotechnology experience and seven approved drugs.

Conexiant

July 17, 2025

FDA Approves Shingrix Prefilled Syringe Option

The FDA has approved a new prefilled syringe presentation of Shingrix to simplify herpes zoster vaccination for eligible adult patients.

Conexiant

July 17, 2025

Nirsevimab Shows 83% Efficacy Over 6 Months

A large clinical trial in Europe showed that a single dose of nirsevimab reduced infant hospitalizations for RSV-associated lower respiratory tract infections by over 80% over a six-month period.

Conexiant

July 17, 2025

Metformin Ineffective for COVID Recovery, Trial Finds

Researchers found metformin did not significantly shorten COVID-19 symptom duration in low-risk outpatients, though it was safe and well tolerated.

Conexiant

July 17, 2025

Cancer History Linked to Severe COVID-19, Study 

Adult childhood cancer survivors had a higher risk of severe COVID-19 despite lower infection rates and higher vaccination coverage.

Conexiant

July 16, 2025

New Guidelines Target Preventive Gaps in Inflammatory Bowel Disease

New clinical recommendations detail updated vaccination and screening protocols to reduce infection and cancer risks in adults with inflammatory bowel disease, particularly those on immune-modifying therapies.

Conexiant

July 14, 2025

Pegivirus in Brain Linked to Parkinson’s Disease

A new study identified human pegivirus in the brains and blood of patients with Parkinson’s disease, revealing virus-linked immune and gene expression changes that varied by genetic background.

Conexiant

July 10, 2025

1 in 4 U.S. Infants Missing Bifidobacterium: Study

Babies who lacked this key gut bacteria were at an increased risk of eczema, allergies, and asthma by age 2.

Conexiant

July 09, 2025

West Nile Virus: Key Clinical Updates

West Nile virus remains the top mosquito-borne illness in the U.S., with high neuroinvasive disease and mortality rates, especially in transplant recipients, according to a new JAMA review.

Conexiant